Health insurance marketplace GoHealth has inked an agreement to buy Medicare-focused e-TeleQuote. The acquisition is expected to close Sept. 30, GoHealth said in a Wednesday (Sept. 4) news release. The company called the acquisition a "significant milestone in GoHealth's mission to deliver unparalleled consumer-centric solutions while reinforcing the companies' shared values of integrity, empathy, and accountability." GoHealth said both firms have deep industry expertise, and each has a "complementary set o ...

CHICAGO and CLEARWATER, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace, today announced that it entered into a purchase and subscription agreement which will ultimately lead to the acquisition of e-TeleQuote Insurance, Inc., a distinguished name in the Medicare insurance marketplace. The transaction is expected to close on September 30, 2024. This strategic move represents a significant milestone in GoHealth's mission to deliver unparalleled co ...

CHICAGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- GoHealth Inc. (NASDAQ: GOCO) ("GoHealth" or the "Company") today announced it will be featured as a presenting company at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held on September 9-11, 2024. The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison Avenue. Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed or ...

CHICAGO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the conclusion of the Alliance of Licensed Medicare Insurance Agencies (ALMIA) Medicare Conference. The event, hosted by GoHealth on Friday, August 16, convened senior healthcare leaders, policymakers, brokers, and innovators from across the healthcare sector to discuss the most pressing issues and emerging opportunities in M ...

Vancouver, British Columbia--(Newsfile Corp. - August 14, 2024) - Go Metals Corp. (CSE: GOCO) ("Go Metals" and/or the "Company") is pleased to report multiple titanium-vanadium-bearing massive oxides occurrences from the reconnaissance program at the KM98 critical metals project. The property is 35 kilometres north of the Lac Tio Mine on the Côte-Nord of Québec. Scott Sheldon, CEO of Go Metals states, "We are seeing very encouraging critical minerals values at surface within all the anomalies at the greenfi ...

Financial Performance - GoHealth reported a quarterly loss of $0.75 per share, significantly better than the Zacks Consensus Estimate of a loss of $2.47, and an improvement from a loss of $1.77 per share a year ago, representing an earnings surprise of 69.64% [1] - The company posted revenues of $105.87 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 23.83%, and down from $142.78 million in the same quarter last year [2] - Over the last four quarters, GoHealth has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Performance - GoHealth shares have declined approximately 13.4% since the beginning of the year, contrasting with the S&P 500's gain of 9% [3] - The current consensus EPS estimate for the upcoming quarter is -$2.52 on revenues of $132.56 million, and for the current fiscal year, it is -$5.26 on revenues of $744.68 million [7] Industry Outlook - The Insurance - Life Insurance industry, to which GoHealth belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact GoHealth's stock performance [5]

Financial Performance - Second quarter 2024 net revenues were $105.9 million, a decrease of $36.9 million (26%) compared to $142.8 million in the prior year period[2]. - The net loss for the second quarter 2024 was $59.3 million, an improvement of $10.9 million compared to a net loss of $70.2 million in the prior year period[2]. - Adjusted EBITDA for the second quarter 2024 was negative $12.3 million, a decrease of $13.1 million compared to positive $0.8 million in the prior year period[2]. - For the first half of 2024, net revenues were $291,470, down 10.6% from $325,937 in the first half of 2023[23]. - Total operating expenses for Q2 2024 were $146,480, down 25.2% from $195,795 in Q2 2023[22]. - The company reported a net income margin of (56.0)% in Q2 2024, compared to (49.2)% in Q2 2023[22]. - Total Medicare Revenue for the three months ended June 30, 2024, was $105,124, a decrease from $138,702 in the same period of 2023, representing a decline of 24%[25]. - Total Agency Revenue for the six months ended June 30, 2024, was $183,803, compared to $235,253 for the same period in 2023, reflecting a decrease of 22%[25]. - Non-Agency Revenue for the three months ended June 30, 2024, was $20,444, down from $28,104 in the same period of 2023, a decline of 27%[25]. Operational Metrics - Submissions in the second quarter 2024 totaled 152,394, reflecting a 6% decrease from 162,837 in the prior year period[2]. - Sales per Submission for the three months ended June 30, 2024, was $690, down from $852 in the same period of 2023, a decrease of 19%[29]. - For the six months ended June 30, 2024, submissions totaled 368,542, down from 376,482, representing a decrease of 7,940 submissions or about 2.1%[30]. - For the six months ended June 30, 2024, sales per submission was $787, compared to $819, a decrease of $32 or 3.9%[30]. - Direct cost of submission for the three months ended June 30, 2024, was $97,618, down from $118,080, a reduction of $20,462[31]. - The direct cost per submission for the three months ended June 30, 2024, was $641, compared to $725 for the same period in 2023[31]. Cash Flow and Assets - Trailing twelve months positive cash flow from operations was $53.8 million, down $32.1 million from $85.9 million in the prior year period[2]. - The company reported a net cash used in operating activities of $(23,984) for the six months ended June 30, 2024, compared to $31,340 in the same period of 2023[28]. - Total current assets decreased to $301,172 as of June 30, 2024, from $476,440 as of December 31, 2023, a decline of 37%[27]. - Total assets decreased to $1,257,075 as of June 30, 2024, from $1,499,570 as of December 31, 2023, reflecting a decrease of 16%[27]. - Total stockholders' equity attributable to GoHealth, Inc. decreased to $202,732 as of June 30, 2024, from $231,014 as of December 31, 2023, a decline of 12%[27]. Marketing and Strategic Initiatives - The company is intensifying targeted marketing efforts in preparation for the upcoming annual enrollment period (AEP) in 67 days[2]. - GoHealth is focusing on leveraging advancements in artificial intelligence and automation to enhance operational efficiency and consumer experience[2]. - The mix of agency versus non-agency agreements is expected to be a key driver of cash flow from operations performance[2]. - GoHealth's proprietary technology aims to deliver more precise, data-driven insights and improve agent efficiency[2].

Company Overview - GoHealth (GOCO) shares increased by 9.2% to close at $13.98, with a notable 28% gain over the past four weeks, supported by solid trading volume [1] - The company is transitioning from a Medicare enrollment company to a Medicare engagement company, focusing on enhancing customer interactions and satisfaction through various initiatives [2][6] Financial Performance - GoHealth is expected to report a quarterly loss of $2.47 per share, reflecting a year-over-year decline of 39.6%, with revenues projected at $140.66 million, down 1.5% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [4] Industry Context - GoHealth operates within the Zacks Insurance - Life Insurance industry, which is currently facing margin pressure, particularly for non-special needs plans, leading to potential benefit disruptions and market exits [5][7] - Despite these challenges, health plans are seeking targeted growth, and GoHealth is well-positioned to assist in achieving this growth in specific markets and products [7] Market Sentiment - The stock currently holds a Zacks Rank 3 (Hold), indicating a neutral sentiment in the market [9]

Core Insights - GoHealth, Inc. has announced changes to its Board of Directors, welcoming two new members, Alan Wheatley and Abhiraj Modi, to fill the vacancies left by Joseph Flanagan and Christopher Litchford [1][2]. Company Overview - GoHealth is a leading health insurance marketplace focused on Medicare, utilizing advanced technology and data science to assist consumers in selecting appropriate healthcare plans [4]. - The company has successfully enrolled millions in Medicare and individual family plans since its inception [4]. Board Changes - Alan Wheatley, former President of Medicare at Humana, brings over thirty years of experience in the Medicare sector, including a decade in senior executive roles at Humana [2]. - Abhiraj Modi, Managing Director at Centerbridge Partners, has over ten years of experience focusing on financial services and healthcare investments [2]. - The addition of Wheatley and Modi is expected to enhance GoHealth's strategic decision-making and commitment to transforming the Medicare Advantage industry [3].

GoHealth welcomes Alan Wheatley, former President of Medicare at Humana, and Abhiraj Modi, Managing Director at Centerbridge Partners as its newest members of the Board, filling the open seats made available by the transitions of Joseph Flanagan and Christopher Litchford off of the board. Mr. Wheatley brings over thirty years of experience in the Medicare space, including over a decade at Humana as a senior executive. Mr. Modi has spent over a decade at Centerbridge focusing on financial services and health ...